Zacks Research Issues Pessimistic Forecast for EMN Earnings

Eastman Chemical (NYSE:EMNFree Report) – Zacks Research cut their Q2 2025 EPS estimates for Eastman Chemical in a research report issued on Tuesday, April 8th. Zacks Research analyst R. Department now anticipates that the basic materials company will post earnings of $2.20 per share for the quarter, down from their prior estimate of $2.23. The consensus estimate for Eastman Chemical’s current full-year earnings is $8.55 per share. Zacks Research also issued estimates for Eastman Chemical’s Q4 2025 earnings at $1.94 EPS and FY2025 earnings at $8.30 EPS.

EMN has been the topic of several other reports. KeyCorp boosted their price objective on shares of Eastman Chemical from $121.00 to $128.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Barclays cut their price target on Eastman Chemical from $111.00 to $108.00 and set an “equal weight” rating on the stock in a report on Monday, February 3rd. StockNews.com raised Eastman Chemical from a “hold” rating to a “buy” rating in a research report on Saturday, January 18th. Mizuho raised Eastman Chemical from a “neutral” rating to an “outperform” rating and set a $105.00 price target for the company in a research report on Thursday, April 3rd. Finally, Royal Bank of Canada upgraded shares of Eastman Chemical from a “sector perform” rating to an “outperform” rating and set a $91.00 price objective on the stock in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $107.75.

Get Our Latest Stock Report on EMN

Eastman Chemical Stock Performance

Shares of EMN stock opened at $81.71 on Wednesday. The company has a market capitalization of $9.41 billion, a P/E ratio of 10.64, a price-to-earnings-growth ratio of 1.22 and a beta of 1.38. Eastman Chemical has a 52 week low of $70.90 and a 52 week high of $114.50. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.78 and a current ratio of 1.51. The company’s 50 day moving average price is $92.98 and its two-hundred day moving average price is $97.71.

Eastman Chemical (NYSE:EMNGet Free Report) last posted its earnings results on Thursday, January 30th. The basic materials company reported $1.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.60 by $0.27. Eastman Chemical had a return on equity of 16.27% and a net margin of 9.65%.

Eastman Chemical Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, April 7th. Stockholders of record on Friday, March 14th were paid a $0.83 dividend. The ex-dividend date of this dividend was Friday, March 14th. This represents a $3.32 annualized dividend and a dividend yield of 4.06%. Eastman Chemical’s dividend payout ratio is presently 43.23%.

Institutional Investors Weigh In On Eastman Chemical

A number of hedge funds have recently added to or reduced their stakes in the company. Raymond James Financial Inc. bought a new position in shares of Eastman Chemical in the fourth quarter valued at $150,537,000. Capital World Investors acquired a new stake in shares of Eastman Chemical in the 4th quarter worth about $137,848,000. Norges Bank bought a new position in Eastman Chemical in the 4th quarter valued at about $137,416,000. Wealthfront Advisers LLC boosted its stake in Eastman Chemical by 3,136.8% during the 4th quarter. Wealthfront Advisers LLC now owns 736,011 shares of the basic materials company’s stock valued at $67,213,000 after purchasing an additional 713,272 shares during the last quarter. Finally, Capital Research Global Investors increased its holdings in Eastman Chemical by 13.4% during the 4th quarter. Capital Research Global Investors now owns 5,886,564 shares of the basic materials company’s stock worth $537,561,000 after purchasing an additional 697,388 shares in the last quarter. Institutional investors and hedge funds own 83.65% of the company’s stock.

Eastman Chemical Company Profile

(Get Free Report)

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

Recommended Stories

Earnings History and Estimates for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.